Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB03242"

PredicateValue (sorted: default)
rdfs:label
"P-Aminophenyl-Alpha-D-Galactopyranoside"
rdf:type
drugbank:description
" experimental This compound belongs to the o-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. O-glycosyl Compounds Organic Compounds Organooxygen Compounds Carbohydrates and Carbohydrate Conjugates Glycosyl Compounds Hexoses Phenol Ethers Alkyl Aryl Ethers Anilines Primary Aromatic Amines Oxanes Secondary Alcohols 1,2-Diols Primary Alcohols Acetals Polyamines phenol ether aniline alkyl aryl ether benzene primary aromatic amine oxane monosaccharide polyol secondary alcohol 1,2-diol acetal primary alcohol polyamine ether amine primary amine alcohol organonitrogen compound logP -1.2 ALOGPS logS -0.92 ALOGPS Water Solubility 3.29e+01 g/l ALOGPS logP -1.4 ChemAxon IUPAC Name (2S,3R,4S,5S,6R)-2-(4-aminophenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol ChemAxon Traditional IUPAC Name (2S,3R,4S,5S,6R)-2-(4-aminophenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol ChemAxon Molecular Weight 271.2665 ChemAxon Monoisotopic Weight 271.105587281 ChemAxon SMILES NC1=CC=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1 ChemAxon Molecular Formula C12H17NO6 ChemAxon InChI InChI=1S/C12H17NO6/c13-6-1-3-7(4-2-6)18-12-11(17)10(16)9(15)8(5-14)19-12/h1-4,8-12,14-17H,5,13H2/t8-,9-,10+,11-,12-/m1/s1 ChemAxon InChIKey InChIKey=MIAKOEWBCMPCQR-RMPHRYRLSA-N ChemAxon Polar Surface Area (PSA) 125.4 ChemAxon Refractivity 64.88 ChemAxon Polarizability 26.49 ChemAxon Rotatable Bond Count 3 ChemAxon H Bond Acceptor Count 7 ChemAxon H Bond Donor Count 5 ChemAxon pKa (strongest acidic) 12.2 ChemAxon pKa (strongest basic) 4.74 ChemAxon Physiological Charge 0 ChemAxon Number of Rings 2 ChemAxon Bioavailability 1 ChemAxon Rule of Five true ChemAxon PubChem Compound 88702 PubChem Substance 46508603 PDB GAT BE0001477 Heat-labile enterotoxin B chain Escherichia coli # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Heat-labile enterotoxin B chain The biological activity of the toxin is produced by the A chain, which activates intracellular adenyl cyclase eltB None 9.12 14134.0 Escherichia coli GenBank Gene Database M17873 GenBank Protein Database 145833 UniProtKB P32890 UniProt Accession ELBP_ECOLX Heat-labile enterotoxin B chain precursor LT-B, porcine LTP-B >Heat-labile enterotoxin B chain precursor MNKVKCYVLFTALLSSLYAHGAPQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVI ITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAI SMKN >375 bp ATGAATAAAGTAAAATGTTATGTTTTATTTACGGCGTTACTATCCTCTCTATATGCACAC GGAGCTCCCCAGACTATTACAGAACTATGTTCGGAATATCGCAACACACAAATATATACG ATAAATGACAAGATACTATCATATACGGAATCGATGGCAGGCAAAAGAGAAATGGTTATC ATTACATTTAAGAGCGGCGAAACATTTCAGGTCGAAGTCCCGGGCAGTCAACATATAGAC TCCCAGAAAAAAGCCATTGAAAGGATGAAGGACACATTAAGAATCACATATCTGACCGAG ACCAAAATTGATAAATTATGTGTATGGAATAATAAAACCCCCAATTCAATTGCGGCAATC AGTATGAAAAACTAG PF01376 Enterotoxin_b component extracellular region process interaction between organisms process interspecies interaction between organisms process symbiosis, encompassing mutualism through parasitism process pathogenesis "
owl:sameAs

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource does not appear as an object

Context graph